Agenda

17/06/2022

Optimizing Immunotherapy: New Approaches, Biomarkers, Sequences and Combinations

Hybrid Congress (8:30h - 16:00 h)

On June 17 will take place a new edition of the Congress "Optimizing Immunotherapy. New Approaches, Biomarkers, Sequences and Combinations”, organized by Dr. Joaquim Bellmunt and Dr. Edurne Arriola. This edition will be also in hybrid format.

In case you need more information please click https://optimizingimmunotherapy.com/

Registration is already open and it's free.

The program is as follows:

08.30 - 08.55 Registration

08.55 - 09.05 Welcome and Opening
Joaquim Bellmunt - Edurne Arriola

09.05 - 09.20 Opening Keynote Lecture
Optimizing Immunotherapy For Kidney Cancer: Lessons from
DF/HCC
David McDermott

09.20 - 10.40 Table 1:Recent Advances of Immunotherapy in the Clinic. Moderator: María Martínez

09.20 - 09.30 Upper GI
David Páez

09.30 - 09.45 Advances on Immunotherapy in GYN tumors
Mary L. (Nora) Disis

09.45 - 09.55 Head and neck
Ricard Mesía

09.55 - 10.10 Discussion

10.10 - 10.20 Moving IO to earlier stages in lung cancer
Noemí Reguart

10.20 - 10.30 IO in earlier stages in bladder cancer
Begoña Pérez-Valderrama

10.30 - 10.40 Discussion

10.40 - 10.50 Coffee break

10.50 - 12.55 Table 2: Biomarkers in Immunotherapy
Moderator: Joan Albanell

10.50 - 11.05 Overview of new Biomarkers predicting immunotherapy response
Josep Maria Piulats

11.05 - 11.20 Integrating AI in the Predicting Algorithms of IO
Craig Davies

11.20 - 11.35 Neoantigens as predictors of response to IO
Mar Albà

11.35 - 11.45 Discussion

11.45 - 12.00 Ex-vivo models for prediction of IO benefit
Israel Cañadas

12.00 - 12.10 New Clinical Trial Endpoints and designs in IO
Benjamin Besse

12.10 - 12.25 The Role of ctDNA in Predicting IO Response/Relapse
Christian Rolfo

12.25 - 12.40 Epigenomics as Predictors for IO Benefit
Paloma Cejas

12.40 - 12.55 Discussion

12.55 - 14.00 Lunch

14.00 - 15.35 Table 3: Futures Perspectives on Immunotherapy. Moderator: Joaquín Arribas

14.00 - 14.15 Vaccines
David Avigan

14.15 - 14.30 Microbiome and cancer
Mònica Bulló

14.30 - 14.45 CAR T-Cells
Sonia Guedan

14.45 - 14.55 Discussion

14.55 - 15.10 Combination: Targeted Therapy +IO
Javier Puente

15.10 - 15.25 Combination: IO + IO
Rosario García-Campelo

15.25 - 15.35 Discussion

15.35 - 15.50 Closing Keynote Lecture
Malignant Melanoma
Stephen Hodi

15.50 - 16.00 Closing Remarks
Joaquim Bellmunt

Download the program.

Contact
Meeting Pharma, A/A Asun Torres
atorres@meetingpharma.com

Todos los actos

Optimizing Immunotherapy: New Approaches, Biomarkers, Sequences and Combinations